atenolol has been researched along with Canine Diseases in 11 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate if pretreatment with atenolol reduces frequency of ventricular arrhythmias, anesthetist interventions, or shortens procedure time." | 5.51 | Effect of preoperative administration of atenolol to dogs with pulmonic stenosis undergoing interventional procedures. ( Borgeat, K; Gomart, S; Hezzell, MJ; MacFarlane, P; Payne, JR, 2022) |
| "Significant differences between pre- and posttreatment number of VPC, severity of arrhythmia, HR variables, or occurrence of syncope were not observed in dogs treated with atenolol or procainamide." | 5.10 | Comparison of the effects of four antiarrhythmic treatments for familial ventricular arrhythmias in Boxers. ( Atkins, CE; DeFrancesco, TC; Gordon, SG; Hamlin, RL; Keene, BW; Meurs, KM; Miller, MW; Moise, NS; Spier, AW; Wright, NA, 2002) |
| "Intoxication with metaproterenol, a mainly beta-2 selective agonist, was diagnosed in a dog with tachycardia, tachypnea, weakness, vomiting, and a history of exposure to the drug." | 3.68 | Metaproterenol intoxication in a dog. ( Keene, BW; Rush, JE, 1990) |
| "Subaortic stenosis (SAS) is a commonly diagnosed canine congenital cardiac defect, with severe forms of carrying a poor long-term prognosis." | 3.11 | Echocardiographic and electrocardiographic effects of atenolol versus sotalol in dogs with severe subaortic stenosis. ( LeBlanc, NL; Owens, EJ; Scollan, KF; Treseder, J, 2022) |
| "Dogs with severe subaortic stenosis (SAS) are at risk of dying suddenly from fatal arrhythmias." | 1.91 | Association of sotalol versus atenolol therapy with survival in dogs with severe subaortic stenosis. ( Obernberger, C; Shear, M; Showers, A; Tjostheim, SS, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Gomart, S | 1 |
| MacFarlane, P | 1 |
| Payne, JR | 1 |
| Hezzell, MJ | 1 |
| Borgeat, K | 1 |
| Owens, EJ | 1 |
| LeBlanc, NL | 1 |
| Treseder, J | 1 |
| Scollan, KF | 1 |
| Tjostheim, SS | 1 |
| Showers, A | 1 |
| Obernberger, C | 1 |
| Shear, M | 1 |
| Barsotti, G | 1 |
| Vezzosi, T | 1 |
| Gladuli, A | 1 |
| Moïse, NS | 2 |
| Hemsley, SA | 1 |
| Otani, NF | 1 |
| Meurs, KM | 2 |
| Spier, AW | 1 |
| Wright, NA | 1 |
| Atkins, CE | 1 |
| DeFrancesco, TC | 1 |
| Gordon, SG | 1 |
| Hamlin, RL | 1 |
| Keene, BW | 2 |
| Miller, MW | 1 |
| Good, L | 1 |
| Côté, E | 1 |
| Wright, KN | 1 |
| Connolly, DJ | 1 |
| Boswood, A | 1 |
| Lehmkuhl, LB | 1 |
| Bonagura, JD | 1 |
| Orton, EC | 1 |
| Herndon, GD | 1 |
| Boon, JA | 1 |
| Gaynor, JS | 1 |
| Hackett, TB | 1 |
| Monnet, E | 1 |
| Rush, JE | 1 |
4 trials available for atenolol and Canine Diseases
| Article | Year |
|---|---|
Effect of preoperative administration of atenolol to dogs with pulmonic stenosis undergoing interventional procedures.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atenolol; Dog Diseases; Dogs; Prospective Stu | 2022 |
Echocardiographic and electrocardiographic effects of atenolol versus sotalol in dogs with severe subaortic stenosis.
Topics: Animals; Anti-Arrhythmia Agents; Aortic Stenosis, Subvalvular; Atenolol; Constriction, Pathologic; C | 2022 |
Comparison of the effects of four antiarrhythmic treatments for familial ventricular arrhythmias in Boxers.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atenolol; Dog Diseases; Dogs; Drug Therapy, C | 2002 |
Survival times in dogs with severe subvalvular aortic stenosis treated with balloon valvuloplasty or atenolol.
Topics: Adrenergic beta-Antagonists; Animals; Aortic Stenosis, Subvalvular; Atenolol; Blood Pressure; Cathet | 2005 |
7 other studies available for atenolol and Canine Diseases
| Article | Year |
|---|---|
Association of sotalol versus atenolol therapy with survival in dogs with severe subaortic stenosis.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Aortic Stenosis, Subvalvular; Atenolol | 2023 |
Keratoconjunctivitis sicca exacerbation in a dog treated with systemic atenolol.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Atenolol; Dog Diseases; Dogs; Keratoconjunctivitis | 2016 |
Poincaré plots and tachograms reveal beat patterning in sick sinus syndrome with supraventricular tachycardia and varying AV nodal block.
Topics: Animals; Anti-Arrhythmia Agents; Atenolol; Atrioventricular Block; Circadian Rhythm; Dog Diseases; D | 2011 |
ECG of the month. Narrow-complex monomorphic tachycardia with a ventricular rate of 320 beats/min.
Topics: Animals; Anti-Arrhythmia Agents; Atenolol; Atrial Fibrillation; Diagnosis, Differential; Digoxin; Do | 2002 |
Dynamic obstruction of the left ventricular outflow tract in four young dogs.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Atenolol; Diagnosis, Differential; Dog D | 2003 |
Influence of open surgical correction on intermediate-term outcome in dogs with subvalvular aortic stenosis: 44 cases (1991-1998).
Topics: Adrenergic beta-Antagonists; Animals; Aortic Stenosis, Subvalvular; Atenolol; Blood Pressure; Cardio | 2000 |
Metaproterenol intoxication in a dog.
Topics: Animals; Arrhythmias, Cardiac; Atenolol; Dog Diseases; Dogs; Echocardiography; Electrocardiography; | 1990 |